BWX Technologies expands capacity and raises $500 million in bond offering
On November 12–13, 2026, BWX Technologies, Inc. completed the C$80 million expansion of its Cambridge manufacturing facility and issued $500 million in senior notes.
BWXT Industrials · 6 analyses · 7 expectations tracked
BWX Technologies reported $953M in revenue (+10.0% YoY), compared with a +11.9% median across covered Industrials peers. Insider tracks 7 open management expectations for this company.
Mentioned in recent filings: Tariffs
On November 12–13, 2026, BWX Technologies, Inc. completed the C$80 million expansion of its Cambridge manufacturing facility and issued $500 million in senior notes.
On November 4, 2026, BWX Technologies, Inc. announced a $500 million new note offering and concurrent buyback of existing debt. The moves aim to manage the company's debt portfolio. The buyback and consent solicitation period ran through November 10, 2026.
In the third quarter of 2026, BWX Technologies reported $953 million in revenue and $102 million in net income. Company achievements included the selection of its BANR technology for new projects and an amendment to its credit agreement.
On November 2, 2026, BWX Technologies, Inc. reported financial results for the third quarter ended September 30, 2026. Revenue rose 10% to $952,972,000 compared to the same period last year.
BWX Technologies, Inc. (BWXT) signed a multi-year agreement with Antares Nuclear, Inc. to produce TRISO fuel at its Virginia facility. Management also clarified that discussions about potential investments in Poland are ongoing, though no final decisions or financial commitments have been made.
BWX Technologies, Inc. received a contract worth about $189 million to produce nuclear fuel for the U.S. Naval program and announced that its BANR technology was chosen for a transportable nuclear electric project in Belledune, Canada.
BWX Technologies, Inc.: 12 recorded developments from 4 official sources in 2026-10.
Monthly records are drafted by AI from each month’s checked filings and official sources (in English, as extracted), with every line linked to its source; storylines group related developments across analyses using vector embeddings (Amazon Titan Text Embeddings V2). Provisional context, not investment advice.
From the 10-Q for the period ended September 30, 2026, filed November 2, 2026. SEC
| Latest | Earlier | Change | |
|---|---|---|---|
| Revenue quarter | $953M | $866M | +10.0% |
| Operating income quarter | $132M | $113M | +16.5% |
| Net income quarter | $102M | $82.1M | +23.9% |
| Diluted EPS quarter | $1.11 | $0.89 | +24.7% |
| Dividends per share quarter | $0.27 | $0.25 | +8.0% |
| Operating cash flow year to date | $452M | $353M | +28.0% |
| Cash and cash equivalents balance | $569M | $500M | +13.8% |
| Long-term debt balance | $2B | $2B | +0.3% |
As the company tagged them in its filing (SEC XBRL). Quarter and year figures are compared with the same period a year earlier, balances with the previous balance sheet. Download CSV
Revenue by quarter, $B
How this company compares with 55 covered companies in Industrials (median revenue change +11.9% YoY), from archived SEC XBRL filings.
| Company | Latest revenue | Revenue YoY | Operating margin |
|---|---|---|---|
| BWX Technologies, Inc. BWXT | $953M | +10.0% | 13.9% |
| Johnson Controls International plc JCI | $25.7B | +8.8% | — |
| RTX Corp RTX | $25B | +11.1% | 13.4% |
| Boeing Co. BA | $24.2B | +3.9% | 1.5% |
| Fedex Corp FDX | $22.9B | +11.9% | 4.7% |
| United Parcel Service Inc UPS | $22.9B | +6.7% | 7.6% |
| Lockheed Martin Corp LMT | $20.7B | +11.3% | 11.8% |
Latest reported period per company from SEC CompanyFacts (XBRL). Fiscal calendars differ across companies.
The company tightened 2026 non-GAAP EPS guidance to $4.72-$4.77.
Not yet checked against later reports.
The company introduced a preliminary outlook calling for high-single-digit revenue growth in 2027.
Not yet checked against later reports.
The company provides expectations and guidance for 2026 and beyond.
Not yet checked against later reports.
Guidance for 2026 non-GAAP EPS is $4.72 - $4.77.
Not yet checked against later reports.
The company tightened 2026 free cash flow guidance to $350 million-$360 million.
Not yet checked against later reports.
The company expects high-single-digit to low-double-digit adjusted EBITDA and non-GAAP EPS growth in 2027.
Not yet checked against later reports.
The transaction to sell the medical business to Nordic Capital is subject to customary regulatory approvals and is expected to be completed in 2026 or in the first quarter of 2027.
Not yet checked against later reports.
What management said to expect (targets, plans, forecasts) in the company's own documents (in English, as extracted), with the date and the period it named. Assessments are written by AI from the company's later reports: provisional, not checked by an editor, and a consistent later report is not proof. An editor's decision replaces them.
| Fund | Shares | Value | Change in shares | Quarter |
|---|---|---|---|---|
| BlackRock | 11,182,315 | $1,531,977,172 | -7.8% | Q3 2026 |
| State Street | 3,972,923 | $544,290,451 | +4.6% | Q3 2026 |
| Geode Capital Management | 1,841,134 | $252,314,257 | -1.1% | Q3 2026 |
| Millennium Management | 1,279,371 | $175,273,827 | +5,799.5% | Q3 2026 |
| ARK Investment Management (Cathie Wood) | 754,114 | $103,313,618 | +37.1% | Q3 2026 |
| Two Sigma Investments | 508,091 | $69,608,467 | +312.8% | Q3 2026 |
| Fidelity (FMR) | 265,065 | $36,313,931 | -65.1% | Q3 2026 |
| Capital Research Global Investors | 257,267 | $35,245,579 | -0.2% | Q3 2026 |
| Citadel Advisors | 103,204 | $14,138,948 | +821.7% | Q3 2026 |
| Bridgewater Associates | 60,920 | $8,346,040 | +270.4% | Q3 2026 |
| D. E. Shaw & Co. | 33,829 | $4,634,573 | +72.3% | Q3 2026 |
| Renaissance Technologies | 11,600 | $2,372,084 | — | Q1 2026 |
| T. Rowe Price | 522,257 | $71,551 | -38.2% | Q3 2026 |
From the quarterly 13F-HR holdings reports of the large funds we follow, as filed. Funds file up to 45 days after the quarter ends, so positions may have changed since. Change: against the same fund's previous quarter. Not a recommendation.